他汀类药物治疗策略对动脉瘤性蛛网膜下腔出血患者缺血性脑血管事件发生率的影响:系统评价与贝叶斯网络Meta分析
该系统评价与贝叶斯网络Meta分析纳入14项研究共2569例动脉瘤性蛛网膜下腔出血患者,6项随机对照试验显示他汀类药物显著改善功能预后(RR 0.73,95%CI 0.55-0.97)并降低缺血性脑血管事件发生率(RR 0.78,95%CI 0.67-0.90)。普伐他汀40 mg/d较安慰剂降低缺血性脑血管事件发生率(RR 0.14,95%CI 0.03-0.65),排名最优。
要点
- 他汀类药物显著降低动脉瘤性蛛网膜下腔出血患者缺血性脑血管事件发生率(RR 0.78,95%CI 0.67-0.90)。
- 6项随机对照试验显示他汀类药物显著改善功能预后(RR 0.73,95%CI 0.55-0.97)。
- 普伐他汀40 mg/d较安慰剂显著降低缺血性脑血管事件发生率(RR 0.14,95%CI 0.03-0.65),排名最优。
核心结论
- 他汀类药物可显著降低动脉瘤性蛛网膜下腔出血患者缺血性脑血管事件发生率并改善功能预后,不同种类和剂量疗效不同。
研究设计与样本
- 系统评价与贝叶斯网络Meta分析,纳入14项研究共2569例动脉瘤性蛛网膜下腔出血患者。
主要发现
- 6项随机对照试验分析显示他汀类药物显著改善功能预后(RR 0.73,95%CI 0.55-0.97)。
- 他汀类药物显著降低缺血性脑血管事件发生率(RR 0.78,95%CI 0.67-0.90)。
- 普伐他汀40 mg/d较安慰剂降低缺血性脑血管事件发生率(RR 0.14,95%CI 0.03-0.65),排名最优。
- 普伐他汀40 mg/d较排名最差的辛伐他汀40 mg/d显著降低缺血性脑血管事件发生率(RR 0.13,95%CI 0.02-0.79)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The exacerbation of neurological outcomes often occurs in aneurysmal subarachnoid hemorrhage (aSAH). Statins have been commonly used for aSAH; however, there is lack of evidence of the pharmacological efficacy of different dosages and types of statins. OBJECTIVE: To apply the Bayesian network meta-analysis to analyze the optimal dosage and type of statins for the amelioration of ischemic cerebrovascular events (ICEs) in patients with aSAH. METHODS: We developed the Bayesian network meta-analysis and systemic review to analyze the effects of statins on functional prognosis and the impacts of optimal dosage and type of statins on ICEs in patients with aSAH. The outcome variables of the analysis were the incidence of ICEs and functional prognosis. RESULTS: A total of 2569 patients with aSAH across 14 studies were included. Analysis of 6 randomized controlled trials showed that statin use significantly improved functional prognosis in patients with aSAH (risk ratio [RR], 0.73; 95% CI, 0.55-0.97). Statins significantly reduced the incidence of ICEs (RR, 0.78; 95% CI, 0.67-0.90). Pravastatin (40 mg/d) decreased the incidence ICEs compared with placebo (RR, 0.14; 95% CI, 0.03-0.65) and was ranked the most effective, presenting with a significantly lower rate of the incidence ICEs than the worst-ranked simvastatin (40 mg/d) (RR, 0.13; 95% CI, 0.02-0.79). CONCLUSION: Statins could significantly diminish the incidence of ICEs and enhance functional prognosis in patients with aSAH. Various types and dosages of statins show distinct efficacies.
引用
- Zhong S, Liu T, Zhai Q, et al. Impacts of Statin Therapy Strategies on Incidence of Ischemic Cerebrovascular Events in Patients With Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Bayesian Network Meta-Analysis. Neurosurgery. 2023. PMID: 36794961. doi:10.1227/neu.0000000000002392
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。